Cardiol Therapeutics (TSE:CRDL) Trading Down 5% - Time to Sell?

Shares of Cardiol Therapeutics Inc. (TSE:CRDL - Get Free Report) fell 5% on Tuesday . The company traded as low as C$1.51 and last traded at C$1.52. 86,322 shares traded hands during trading, an increase of 35% from the average session volume of 64,026 shares. The stock had previously closed at C$1.60.

Cardiol Therapeutics Trading Down 4.8 %

The stock has a market cap of C$114.51 million, a price-to-earnings ratio of -2.71 and a beta of 0.70. The company has a debt-to-equity ratio of 1.59, a current ratio of 2.49 and a quick ratio of 6.84. The company's fifty day moving average price is C$1.75 and its 200-day moving average price is C$2.16.

Cardiol Therapeutics Company Profile

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.